Covington Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $60K | Hold |
704
| – | – | ﹤0.01% | 535 |
|
|
2022
Q2 | $58K | Buy |
704
+204
| +41% | +$16.8K | ﹤0.01% | 530 |
|
|
2022
Q1 | $39K | Hold |
500
| – | – | ﹤0.01% | 614 |
|
|
2021
Q4 | $44K | Hold |
500
| – | – | ﹤0.01% | 568 |
|
|
2021
Q3 | $39K | Hold |
500
| – | – | ﹤0.01% | 577 |
|
|
2021
Q2 | $42K | Buy |
500
+294
| +143% | +$24.7K | ﹤0.01% | 559 |
|
|
2021
Q1 | $16K | Hold |
206
| – | – | ﹤0.01% | 634 |
|
|
2020
Q4 | $18K | Hold |
206
| – | – | ﹤0.01% | 593 |
|
|
2020
Q3 | $16K | Hold |
206
| – | – | ﹤0.01% | 577 |
|
|
2020
Q2 | $25K | Hold |
206
| – | – | ﹤0.01% | 522 |
|
|
2020
Q1 | $17K | Hold |
206
| – | – | ﹤0.01% | 545 |
|
|
2019
Q4 | $17K | Hold |
206
| – | – | ﹤0.01% | 615 |
|
|
2019
Q3 | $14K | Hold |
206
| – | – | ﹤0.01% | 605 |
|
|
2019
Q2 | $18K | Hold |
206
| – | – | ﹤0.01% | 566 |
|
|
2019
Q1 | $18K | Hold |
206
| – | – | ﹤0.01% | 548 |
|
|
2018
Q4 | $18K | Hold |
206
| – | – | ﹤0.01% | 560 |
|
|
2018
Q3 | $20K | Hold |
206
| – | – | ﹤0.01% | 531 |
|
|
2018
Q2 | $19K | Hold |
206
| – | – | ﹤0.01% | 559 |
|
|
2018
Q1 | $17K | Hold |
206
| – | – | ﹤0.01% | 575 |
|
|
2017
Q4 | $18K | Buy |
+206
| New | +$18K | ﹤0.01% | 603 |
|